Lab Tests Online-UK
Lab Tests Online-UK is written by practising laboratory doctors and scientists to help you understand the many clinical laboratory tests that are used in diagnosis, monitoring and treatment of disease. The about this site page describes how the site can help you. Search under conditions and diseases and find information on laboratory tests used for particular diagnosis and/or management or alternatively, if you know the test name, just search under tests.
A new DNA blood test for Rhesus-D negative women during pregnancy could spare treatment for thousands
A new prenatal DNA blood test reliably determines the Rhesus-D (RhD) status of the baby being carried by a woman whose red blood cells are RhD negative. Currently all RhD negative women are offered an anti-D immunoglobulin injection during pregnancy to reduce the possibility of problems in future pregnancies. But those carrying an RhD negative baby do not need the injection. The new test was recommended by the National Institute for Health and Care Excellence (NICE) in draft guidance on 14 July 2016. NICE said research indicated that about 40,000 RhD negative women each year would be spared treatment with anti-D immunoglobulin; in addition there would be potential NHS cost-savings of more than £50,000 a year.
In Dr James Le Fanu’s online health clinic, published in the Daily Telegraph on Tuesday 28 June 2016, visitors were directed to Lab Tests Online-UK as a result of a letter submitted to the online health clinic. A reader wrote to inform Dr Le Fanu of the website, and described it as a useful, respectable source of information, endorsed by the Royal College of Pathologists.
The World Health Organization (WHO) released recommendations on 12 May 2016 that aim to speed up the detection, and improve the treatment of multidrug resistant tuberculosis (MDR-TB). A novel molecular diagnostic test is recommended for use in national TB reference laboratories that can identify genetic mutations in MDR-TB strains within 24 – 48 hours and reliably rule out resistance to second-line TB drugs. Early detection of MDR-TB has been one of the major bottlenecks in tackling the global TB epidemic.